Astellas Pharma's total assets for Q4 2024 were ¥3.34T, a decrease of -3.25% from the previous quarter. ALPMF total liabilities were ¥1.83T for the fiscal quarter, a -6.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.